Nisa Investment Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
Nisa Investment Advisors's HCAT Position: Q2 2026 in Review
Nisa Investment Advisors opened a new position in Health Catalyst (HCAT) in Q2 2026: 237 shares worth $472. The stake represents ﹤0.01% of the portfolio and ranks #2955 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in HCAT as recently as Q3 2025.
Nisa Investment Advisors first reported a position in HCAT in Q3 2020 and has held it in 22 quarters since. The position peaked at $114K in Q2 2021. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Nisa Investment Advisors held 237 shares of Health Catalyst worth $472 as of Q2 2026.
- Health Catalyst was a new Nisa Investment Advisors position in Q2 2026.
- Health Catalyst made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2955 holding.
- Nisa Investment Advisors first reported a position in Health Catalyst in Q3 2020 and has held it in 22 quarters since.
- Nisa Investment Advisors's Health Catalyst position peaked at $114K in Q2 2021.
- 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.